Sharekhan

Diamines and Chemicals Ltd

Wed 21/05/2025,15:54:3 | NSE : DIAMINESQ

₹ 383.503.95 (1.04%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 383.55

Previous Close

₹ 379.55

Volume

5076

Mkt Cap ( Rs. Cr)

₹375.22

High

₹ 392.00

Low

₹ 381.15

52 Week High

₹ 693.40

52 Week Low

₹ 305.15

Book Value Per Share

₹ 166.44

Dividend Yield

0.65

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Diamines and Chemicals Ltd

Your Vote -

Buy

80.00%

Hold

10.00%

Sell

10.00%

80.00%

10 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

383.50

19

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

19

Option Chain

Analyzes market sentiment, predicts Diamines and Chemicals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Diamines & Chem. - Board Meeting Intimation

    16 May 2025, 5:42PM DIAMINES & CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 29-May-2025 to consider and approve the Yearly Audited Financ
  • Diamines & Chem. - Update on board meeting

    16 May 2025, 5:33PM The Board Meeting to be held on 19/05/2025 has been revised to 29/05/2025 With reference to the earlier announcement dated May 05, 2025 regarding inti
  • Diamines & Chem. - Board Meeting Intimation

    5 May 2025, 5:55PM DIAMINES & CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 19-May-2025 to consider and approve the Yearly Audited Financ
  • Diamines & Chem. - Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results (Standalone & Con

    5 May 2025, 5:33PM Diamines & Chemicals Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 ,inter alia, to conside
  • Diamines & Chem. - Disclosure under SEBI Takeover Regulations

    15 Apr 2025, 8:39PM Amit M mehta has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acqu
  • Diamines & Chem. - Disclosure under SEBI Takeover Regulations

    15 Apr 2025, 1:17PM Amit Mahendrakumar Mehta has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Subs
  • Diamines & Chem. has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    10 Apr 2025, 4:20PM As of March 2025, 55.17% is owned by Indian Promoters and 44.82% by Public. <p align=justify> Top five Promoters holding highest number of shares of D
  • Diamines & Chem. - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    3 Apr 2025, 5:17PM Diamines & Chemicals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Diamines & Chem. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    3 Apr 2025, 5:10PM We herewith submit certificate received from MUFG Intime India Private Ltd under Reg 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March
  • Diamines & Chem. - Trading Window-XBRL

    27 Mar 2025, 9:52AM DIAMINES & CHEMICALS LIMITED has informed the Exchange about Closure of Trading Window
  • Diamines & Chem. - Trading Window

    27 Mar 2025, 9:51AM Diamines & Chemicals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulati

Key fundamentals

Evaluate the intrinsic value of Diamines and Chemicals Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 150.7764 134.8901 100.2424 85.3281 65.1797
Liabilities 150.7764 134.8901 100.2424 85.3281 65.1797
Equity 9.784 9.7832 9.7832 9.7832 9.7832
Gross Profit 24.2017 55.766 22.0389 25.1524 35.2308
Net Profit 17.7713 42.2195 16.7235 21.0337 23.9858
Cash From Operating Activities 19.7348 16.3061 27.3142 15.3733 25.9542
NPM(%) 17.08 38.18 25.29 33.48 34.61
Revenue 104.0351 110.5586 66.1068 62.8171 69.2993
Expenses 79.8334 54.7926 44.0679 37.6647 34.0685
ROE(%) 10.91 25.92 10.26 12.91 14.72

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
25 Jul 2024 2.5 25 0.65 551.15

Peers

Other companies within the same industry or sector that are comparable to Diamines and Chemicals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Finolex Industries Ltd 189.98 0.56 14.73 23571.50 381.63 1.32
Styrenix Performance Materials Ltd 2990.30 1.16 23.03 670.53 984.72 3.28
Arabian Petroleum Ltd 76.35 -0.13 10.43 415.20 62.48 0.00
Bhansali Engineering Polymers Ltd 114.65 0.05 15.86 9486.47 723.36 3.49

Company Info

YEAR EVENTS 1976 - The Company was incorporated as a Public Limited Company on 12th May, and it obtained the Certificate of Commencement of Business on 16th July, from the Registrar of Companies, Gujarat at Ahmedabad. - The Company was jointly promoted by the Bharat Vijay Mills Ltd., Kalol (Gujarat) and Cellulose Products of India Ltd. - The main objective of the company is to manufacture of ethylenediamine and polamines such as diethylenetriamine, triethlenetetramine and other polyethylene polyamines used mainly for the manufacture of pesticides and fungicides, textiles, auxiliaries, paints and adhesives, drug intermediates, auxiliaries, paints and adhesives, drug intermediates, paper, petroleum additives, rubber chemicals and plastics. - 40,000 shares issued to promoters, directors, etc. 3,60,000 shares issued at par out of which the following shares were reserved and allotted: 5,20,000 shares to The Bharat Vijay Mills Ltd., and Cellulose Products of Indian Ltd., 50,000 shares each to LIC and GIC and 70,000 shares to employees and business associates of the two promoter companies. 6,70,000 shares offered for public subscription during November 1979. 1983 - The company achieved an average capacity utilisation of 58% as against 14% in the previous year. - 4,48,000 rights equity shares issued at par in prop. 8:25 in 1985 - The profitability, however, was adversely affected due to factors such as increase in the cost of inputs and higher downtime in some of the initial equipment subject to corrosion, power tripping, etc. The company installed a 500 KVA diesel generating set. 1988 - A letter of intent was received from enhancement of ethylenediamine capacity from 2,000 tpa to 5,000 tpa. 1989 - During the period, the company entered into a Co-promoters Agreement with PICUP for Rifampicin Project of 100 tpa capacity. 1990 - The Company undertook implementation of phase-III of modernisation-cum-expansion programme to expand the installed capacity to 2,600 tpa. - A Company in the name and style of Hindustran Biotech Ltd. (HBL), was incorporated for setting up the said bulk drug project. 1991 - The company received offers from Grace Rexolin, Sweden (W.R. Grace, U.S.A.) for the technology know-how for manufacture of N-methyl piperazine (NMP), ammino methyl piperazine (AMP) and N-ethyl piperazine (NEP), etc. - The HBL unit was at an advanced stage for setting up the bulk drugs project at Sikandrabad, U.P. PICUP sanctioned the necessary loans for the same. - During the year, the Company signed a Memorandum of Understanding with the Gujarat Industrial Investment Corporation Ltd. (GIIC), to set upan integrated chemical complex in the joint sector for the manufacture of ethylenedichloride (EDC) in the backward area of Gujarat State. - The company issued 1,25,000-20% secured redeemable non-convertible debentures of Rs. 100 each on private placement basis with UTI (75,000 debentures) and LIC (50,000 debentures). - The debenture issued to UTI are redeemable in three equal annual instalments commencing from 7th February, 1997 and ending on 7th February, 1999 and the debentures issued to LIC are redeemable in three equal annual installments commencing from the February 1998 and ending on 7th February, 2000. - 50,580 No. of equity shares of Rs. 10 each at a premium of Rs. 28.75 per share. 2008 - Company has informed that the designated Email Id of the grievance redressal division/compliance officer exclusively for the purpose of registering complaints by investor is: secretarial@dacl.co.in 2010 - Diamines & Chemicals Ltd has appointed Mr. Girish R. Satarkar as an Executive Director w.e.f. April 13, 2010. 2011 -Diamines & Chemicals has given the Bonus in the Ratio of 1:2 2012 - The company has recommended dividend @ 10% (Rs. 1/- per Equity Share). 2013 - The company has recommended dividend @ 5% (Rs. 0.50 per Equity Share).

YEAR EVENTS 1976 - The Company was incorporated as a Public Limited Company on 12th May, and it obtained the Certificate of Commencement of Business on 16th July, from the Registrar of Companies, Gujarat at Ahmedabad. - The Company was jointly promoted by the Bharat Vijay Mills Ltd., Kalol (Gujarat) and Cellulose Products of India Ltd. - The main objective of the company is to manufacture of ethylenediamine and polamines such as diethylenetriamine, triethlenetetramine and other polyethylene polyamines used mainly for the manufacture of pesticides and fungicides, textiles, auxiliaries, paints and adhesives, drug intermediates, auxiliaries, paints and adhesives, drug intermediates, paper, petroleum additives, rubber chemicals and plastics. - 40,000 shares issued to promoters, directors, etc. 3,60,000 shares issued at par out of which the following shares were reserved and allotted: 5,20,000 shares to The Bharat Vijay Mills Ltd., and Cellulose Products of Indian Ltd., 50,000 shares each to LIC and GIC and 70,000 shares to employees and business associates of the two promoter companies. 6,70,000 shares offered for public subscription during November 1979. 1983 - The company achieved an average capacity utilisation of 58% as against 14% in the previous year. - 4,48,000 rights equity shares issued at par in prop. 8:25 in 1985 - The profitability, however, was adversely affected due to factors such as increase in the cost of inputs and higher downtime in some of the initial equipment subject to corrosion, power tripping, etc. The company installed a 500 KVA diesel generating set. 1988 - A letter of intent was received from enhancement of ethylenediamine capacity from 2,000 tpa to 5,000 tpa. 1989 - During the period, the company entered into a Co-promoters Agreement with PICUP for Rifampicin Project of 100 tpa capacity. 1990 - The Company undertook implementation of phase-III of modernisation-cum-expansion programme to expand the installed capacity to 2,600 tpa. - A Company in the name and style of Hindustran Biotech Ltd. (HBL), was incorporated for setting up the said bulk drug project. 1991 - The company received offers from Grace Rexolin, Sweden (W.R. Grace, U.S.A.) for the technology know-how for manufacture of N-methyl piperazine (NMP), ammino methyl piperazine (AMP) and N-ethyl piperazine (NEP), etc. - The HBL unit was at an advanced stage for setting up the bulk drugs project at Sikandrabad, U.P. PICUP sanctioned the necessary loans for the same. - During the year, the Company signed a Memorandum of Understanding with the Gujarat Industrial Investment Corporation Ltd. (GIIC), to set upan integrated chemical complex in the joint sector for the manufacture of ethylenedichloride (EDC) in the backward area of Gujarat State. - The company issued 1,25,000-20% secured redeemable non-convertible debentures of Rs. 100 each on private placement basis with UTI (75,000 debentures) and LIC (50,000 debentures). - The debenture issued to UTI are redeemable in three equal annual instalments commencing from 7th February, 1997 and ending on 7th February, 1999 and the debentures issued to LIC are redeemable in three equal annual installments commencing from the February 1998 and ending on 7th February, 2000. - 50,580 No. of equity shares of Rs. 10 each at a premium of Rs. 28.75 per share. 2008 - Company has informed that the designated Email Id of the grievance redressal division/compliance officer exclusively for the purpose of registering complaints by investor is: secretarial@dacl.co.in 2010 - Diamines & Chemicals Ltd has appointed Mr. Girish R. Satarkar as an Executive Director w.e.f. April 13, 2010. 2011 -Diamines & Chemicals has given the Bonus in the Ratio of 1:2 2012 - The company has recommended dividend @ 10% (Rs. 1/- per Equity Share). 2013 - The company has recommended dividend @ 5% (Rs. 0.50 per Equity Share).

Read More

Parent Organisation

Diamines & Chemicals Ltd.

Founded

12/05/1976

Managing Director

Mr.Amit Mehta

NSE Symbol

DIAMINESQEQ

FAQ

The current price of Diamines and Chemicals Ltd is ₹ 383.50.

The 52-week high for Diamines and Chemicals Ltd is ₹ 392.00 and the 52-week low is ₹ 381.15.

The market capitalization of Diamines and Chemicals Ltd is currently ₹ 375.22. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Diamines and Chemicals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Diamines and Chemicals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Diamines and Chemicals Ltd shares.

The CEO of Diamines and Chemicals Ltd is Mr.Amit Mehta, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT